Health
Pfizer’s vaccine offers COVID-19 protection after first dose, FDA says – Sydney Morning Herald
Pfizer has cleared the next hurdle in the race to get its COVID-19 vaccine approved for emergency use in the US.
The agency typically follows the recommendations of its advisory panels but is not required to do so.
The good news is that this very important part of the process is playing out just like it should and just like it does with every other FDA regulatory review process, said Dr Helen Boucher, Chief of Infectious Diseases at Tufts Medical Centre, in an interview with Reuters.
Data from the trial showed that the vaccine began conferring some protection to recipients even before they received the second…
-
Noosa News12 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
General14 hours agoAustralian luger Alex Ferlazzo makes stunning recovery during run after falling off his sled
-
Business24 hours agoWhat Warren Buffett’s latest portfolio moves say about the market
-
Business18 hours agoCounter drone company surges past $1 billion valuation with new contract win